tiprankstipranks
Trending News
More News >
National Healthcare Properties (HLTC)
OTHER OTC:HLTC
US Market

National Healthcare Properties (HLTC) AI Stock Analysis

Compare
28 Followers

Top Page

HLTC

National Healthcare Properties

(OTC:HLTC)

Select Model
Select Model
Select Model
Underperform 37 (OpenAI - 4o)
Rating:37Underperform
Price Target:
$5.00
▼(-32.43% Downside)
The overall stock score for HLTC is heavily impacted by poor financial performance, with declining revenues, high leverage, and negative cash flows posing significant risks. Technical analysis supports a bearish outlook, with the stock trading below key moving averages and momentum indicators in oversold territory. Valuation metrics further highlight profitability challenges, resulting in a low overall score.
Positive Factors
New Credit Agreement
The new $400 million revolving credit facility and $150 million term loan enhance liquidity and financial flexibility, supporting long-term growth and operational stability.
Leadership Change
The new CFO brings extensive experience in financial strategy and investor relations, likely improving financial management and supporting strategic growth.
Revenue Model
The business model of long-term net leases with periodic rent escalations ensures stable revenue streams and potential growth, enhancing financial predictability.
Negative Factors
High Leverage
High leverage poses a risk in a rising interest rate environment, potentially straining financial resources and limiting strategic flexibility.
Negative Cash Flow
Negative cash flow from operations indicates challenges in generating sufficient cash to support operations and debt obligations, impacting financial stability.
Declining Revenue
Declining revenue growth reflects challenges in maintaining market position and could hinder long-term profitability and expansion efforts.

National Healthcare Properties (HLTC) vs. SPDR S&P 500 ETF (SPY)

National Healthcare Properties Business Overview & Revenue Model

Company DescriptionNational Healthcare Properties (HLTC) is a real estate investment trust (REIT) focused on acquiring, owning, and managing healthcare-related properties across the United States. The company primarily invests in senior housing, skilled nursing facilities, and other healthcare real estate assets, catering to the growing demand for healthcare services driven by an aging population. HLTC aims to provide stable and attractive returns for its investors by leveraging its expertise in the healthcare sector and maintaining a diversified portfolio of properties.
How the Company Makes MoneyNational Healthcare Properties generates revenue primarily through leasing its healthcare properties to operators who provide medical and residential care services. The company typically enters long-term net leases with these operators, which obligate them to cover property expenses such as maintenance, taxes, and insurance, allowing HLTC to receive consistent rental income. Additionally, HLTC may benefit from periodic rent escalations, which are built into the lease agreements, enhancing revenue growth over time. The company also strategically acquires properties that have the potential for appreciation in value, contributing to its overall earnings through capital gains. Partnerships with reputable healthcare operators and a focus on high-demand markets further strengthen its revenue model.

National Healthcare Properties Financial Statement Overview

Summary
National Healthcare Properties is facing financial difficulties, with declining revenues and persistent losses impacting profitability. The high leverage and negative cash flows present significant risks. The company needs to focus on improving operational efficiency and cash flow management to stabilize its financial position.
Income Statement
35
Negative
National Healthcare Properties has experienced declining revenue growth, with a negative growth rate of -0.99% in the TTM period. The company is facing profitability challenges, as evidenced by negative net profit margins and EBIT margins. The gross profit margin has been relatively stable but insufficient to cover operating expenses, leading to negative net income.
Balance Sheet
40
Negative
The company has a high debt-to-equity ratio, indicating significant leverage, which poses a risk in a rising interest rate environment. The return on equity is negative, reflecting ongoing losses. However, the equity ratio is relatively stable, suggesting some balance sheet resilience.
Cash Flow
30
Negative
Cash flow from operations is negative, and free cash flow has deteriorated significantly, with a negative growth rate of -76.4% in the TTM period. The operating cash flow to net income ratio is unfavorable, indicating cash flow challenges. The company needs to improve its cash generation to support operations and debt obligations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue259.47M353.79M345.93M335.85M329.36M381.61M
Gross Profit39.69M132.65M128.13M122.40M123.54M138.06M
EBITDA86.33M-22.36M76.87M53.76M42.59M61.12M
Net Income-55.24M-189.70M-72.30M-79.62M-85.18M-75.81M
Balance Sheet
Total Assets1.74B1.95B2.15B2.18B2.21B2.29B
Cash, Cash Equivalents and Short-Term Investments47.06M21.65M46.41M53.65M59.74M72.36M
Total Debt0.001.15B1.18B1.12B1.09B1.23B
Total Liabilities1.11B1.26B1.24B1.18B1.17B1.33B
Stockholders Equity627.22M684.56M894.15M992.64M1.03B956.99M
Cash Flow
Free Cash Flow-19.02M-101.75M-773.00K302.00K19.81M19.91M
Operating Cash Flow3.45M-79.85M21.62M28.30M38.88M41.81M
Investing Cash Flow78.55M63.97M-62.82M-41.78M-47.92M-82.49M
Financing Cash Flow-64.37M-1.35M55.97M4.64M4.08M19.43M

National Healthcare Properties Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price7.40
Price Trends
50DMA
7.78
Negative
100DMA
7.72
Negative
200DMA
7.81
Negative
Market Momentum
MACD
-0.21
Positive
RSI
50.61
Neutral
STOCH
28.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLTC, the sentiment is Neutral. The current price of 7.4 is below the 20-day moving average (MA) of 7.67, below the 50-day MA of 7.78, and below the 200-day MA of 7.81, indicating a bearish trend. The MACD of -0.21 indicates Positive momentum. The RSI at 50.61 is Neutral, neither overbought nor oversold. The STOCH value of 28.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HLTC.

National Healthcare Properties Risk Analysis

National Healthcare Properties disclosed 83 risk factors in its most recent earnings report. National Healthcare Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

National Healthcare Properties Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$170.43M20.9252.29%4.62%29.76%22.76%
69
Neutral
$544.82M30.3210.55%7.51%0.68%-1.34%
66
Neutral
$444.44M-39.89-2.32%12.08%3.40%-240.85%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
58
Neutral
$1.21B-3.42-18.84%0.80%4.10%8.96%
55
Neutral
$479.74M-133.010.49%10.01%2.73%-131.16%
37
Underperform
$217.23M-3.30-11.41%-2.72%69.06%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLTC
National Healthcare Properties
7.64
-0.38
-4.74%
DHC
Diversified Healthcare Trust
5.01
2.83
129.82%
CHCT
Community Healthcare
15.61
-0.88
-5.34%
GMRE
Global Medical REIT
32.96
-2.68
-7.52%
UHT
Universal Health Realty Income
39.27
4.44
12.75%
STRW
Strawberry Fields REIT Inc
12.99
2.87
28.36%

National Healthcare Properties Corporate Events

Private Placements and Financing
National Healthcare Properties Secures New Credit Agreement
Neutral
Dec 11, 2025

On December 11, 2025, National Healthcare Properties, Inc., along with its Operating Partnership and certain subsidiaries, entered into a new credit agreement with Wells Fargo Bank and other lenders. This agreement includes a $400 million senior unsecured revolving credit facility and a $150 million senior unsecured term loan facility, replacing a previous loan agreement from 2019. The new facilities, which mature in 2028, are intended for general corporate purposes and allow for potential increases in lending commitments. The agreement imposes various financial covenants and conditions, with the possibility of prepayment without penalty.

Executive/Board Changes
National Healthcare Properties Appoints New CFO Amid Leadership Change
Neutral
Nov 18, 2025

On November 18, 2025, National Healthcare Properties announced the appointment of Andrew T. Babin as Chief Financial Officer and Treasurer, following the resignation of Scott M. Lappetito. Babin, who previously held significant roles in financial strategy and investor relations, brings extensive experience in capital markets and investor relations, which is expected to enhance NHP’s strategic financial management and support its growth in the healthcare real estate sector. Lappetito’s departure was amicable, and he entered into a separation agreement with the company.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 20, 2025